SCHEMBL7234709

SCHEMBL7234709

COc1cc(F)cc(OC)c1.OBO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
NQO2 P16083 1/20 0.45
CYP1A1 P04798 4/20 0.42
CYP1B1 Q16678 4/20 0.42
CYP3A4 P08684 3/20 0.41
ABL1 P00519 1/20 0.40
ABCB1 P08183 1/20 0.40
BCR P11274 1/20 0.40
PTGS1 P23219 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2E1 P05181 2/20 0.38
CYP2C8 P10632 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2A6 P11509 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP4B1 P13584 2/20 0.38
CYP2B6 P20813 2/20 0.38
CYP3A5 P20815 2/20 0.38
CYP2A7 P20853 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168353 0.89 ALDH1A1 (0.69) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
SCHEMBL12093245 0.87 ALDH1A1 (0.46) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
SCHEMBL186502 0.84 ALDH1A1 (0.59) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
SCHEMBL257740 0.82 ALDH1A1 (0.40) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
Methane SCHEMBL28126699 0.81 ALDH1A1 (0.56) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
SCHEMBL4043764 0.81 ALDH1A1 (0.50) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
SCHEMBL30214003 0.78 CA1 (0.55) ALDH1A1CYP1A1CYP1B1CYP3A4ABL1
SCHEMBL522123 0.78 CA1 (0.55) ALDH1A1CYP1A1CYP1B1CYP3A4ABL1
SCHEMBL30516653 0.78 ALDH1A1 (0.46) ALDH1A1NQO2CYP1A1CYP1B1CYP3A4
SCHEMBL1689762 0.78 NFE2L2 (0.59) ALDH1A1CYP3A4CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed
WO-2000071572-A1 SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2000-11-30 WO disclosed